期刊文献+

采用受试者工作特征曲线分析鳞状细胞癌抗原在宫颈癌诊断中的价值

The evaluation of the clinical value of serum SCC-Ag in diagnosis of cervical cancer
下载PDF
导出
摘要 目的采用受试者工作特征曲线(ROC)分析法评价血清鳞状细胞癌抗原(SCC-Ag)水平检测在宫颈癌诊断中的临床应用价值。方法收集88例宫颈癌患者和103例健康体检者血样和资料,采用酶联免疫吸附试验测定所有对象血清SCC-Ag水平。采用MedCalc软件绘制ROC,对血清SCC-Ag诊断宫颈癌的准确性进行评价。结果与健康对照组相比较,宫颈癌组血清SCC-Ag水平均有明显升高,差异有统计学意义(P<0.05);ROC显示,血清SCC-Ag诊断宫颈癌的灵敏度为78.4%,AUC特异性为80.5%,ROC下面积为0.80。结论血清SCC-Ag水平与宫颈癌的发生密切相关,血清SCC-Ag水平检测在宫颈癌的诊断中有较好的临床应用价值。 Objective To evaluate the clinical diagnostic value of serum squamous cell carcinoma antigen(SCC-Ag) by ROC curve in diagnosis of cervical cancer.Methods The serum level of squamous cell carcinoma antigen(SCC-Ag) in 88 cervical carcinoma patients(experimental group) and 103 healthy individuals(control group) were detected by Enzyme-linked immunosorbent assay.A ROC curve was used to evaluate the accuracy of serum SCC-Ag in the diagnosis of cervical cancer.Results Serum SCC-Ag levels in the experimental group were significantly higher than that in the control group(P0.05).The sensitivity,specificity of serum SCC-Ag diagnosing cervical cancer were 78.4% and 80.5%,respectively.The area under the ROC curve was 0.80.Conclusion It is suggested that serum SCC-Ag levels is closely related to cervical cancer.The serum SCC-Ag level is a useful diagnostic marker in cervical cancer.
出处 《检验医学与临床》 CAS 2011年第22期2747-2748,共2页 Laboratory Medicine and Clinic
关键词 鳞状细胞癌抗原 宫颈癌 受试者工作特征曲线 诊断价值 squamous cell carcinoma antigen cervical cancer ROC curve diagnosis value
  • 相关文献

参考文献8

  • 1张彦娜,张昌卿,王骅,梁伊仁.宫颈癌患者中联合检测血清VEGF及SccAg的意义[J].中国癌症杂志,2002,12(3):231-233. 被引量:12
  • 2刘晓玲,车少敏,王文,姜缨,郑伟.血清SCC与宫颈癌生物学行为的相关性及临床意义[J].西安交通大学学报(医学版),2004,25(6):576-577. 被引量:16
  • 3Howe HL,Wu X,Ries LA,et al. Annual report to the na- tion on the status of cancer[J]. Cancer, 2006,107 (8): 1711-1742.
  • 4Sherman ME,Wang SS, Carreon J, et al. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival [J].Cancer, 2005,103(6) : 1258-1264.
  • 5熊樱,梁立治,郑敏,魏梅,沈扬.鳞状细胞癌抗原与子宫颈鳞状细胞癌的临床病理特征及预后的关系[J].中华妇产科杂志,2007,42(1):29-33. 被引量:36
  • 6Kotowicz B,Fuksiewicz M,Kowalska M, et al. The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients [J]. Int J Gynecol Cancer, 2008,18 (6) : 1279-1284.
  • 7De Bruijn HW,Duk TM,Van der Zee AG,et al. The clini- cal value of squarnous cell carcinoma antigen in cancer of the uterine cervix[J]. Tumour Biol, 1998,19(6) :505-516.
  • 8Molina R, Filella X, Lejarcegui JA, et al. Prospective eval- uation of squamous eel1 carcinoma and earcinoembryonic antigen as prognostic factors in patients with cervical eaneer[J]. Tumour Biol,2003,24(3) : 156-164.

二级参考文献16

  • 1荆结线,邵淑丽,田保国,韩存芝,赵先文,杜丽丽,张中书.宫颈癌SCCAg检测及其临床意义[J].中国肿瘤临床,2005,32(21):1242-1244. 被引量:13
  • 2连丽娟.林巧稚妇科肿瘤学(第2版)[M].北京:人民卫生出版社,1994.533-544.
  • 3Duk JM, Groeneier KH, de Bruijn HW, et al. Pre-treatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma [J]. J Clin Oncol 1996,14(1):111-118.
  • 4Maruo T, Shibatu K, Kimura A, et al. Tumor associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix:Serial determinations and tissue localization [J]. Cancer,1985,(56):302-308.
  • 5Ngan HY, Cheung AN, Lauder IJ, et al. Prognostic significance of serum tumor markers in carcinoma of the cervix [J]. Eur J Gynaecol Oncol,1996,17(6):512-517.
  • 6Gaarenstroom KN, Bonfrer JMG, Korse CM, et al.Value of Cyfra21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer [J]. Anticancer Res,1997,17(48):2955-2958.
  • 7Yazigi R,Munoz AK,Richardson B,et al.Correlation of squamous cell carcinoma antigen levels and treatment response in cervical cancer.Gynecol Oncol,1991,41:135-138.
  • 8Rose PG,Baker S,Fournier L,et al.Serum squamous cell carcinoma antigen levels in invasive cervical cancer:prediction of response and recurrence.Am J Obstet Gynecol,1993,168:942-946.
  • 9Duk JM,Groenier KH,de Bruijn HW,et al.Pretreatment serum squamous cell carcinoma antigen:a newly identified prognostic factor in early-stage cervical carcinoma.J Clin Oncol,1996,14:111-118.
  • 10丸尾猛 吉村茂树.子宮頚癌と腫瘍マーカー[J].産婦人科治療,1999,79:65-70.

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部